Later on, Bouchard et al. showed that transgenic mice carrying the activated NEU oncogene under the control of MMTV-LTR developed multiple mammary tumors asynchronously, indicating that NEU overexpression was necessary but not sufficient for the complete malignant transformation of the mammary epithelium [85]. The gene discussed is ERBB2; the disease is breast cancer.